Trial Outcomes & Findings for Embryo Transfer With Self-spent Culture Medium (NCT NCT03728140)
NCT ID: NCT03728140
Last Updated: 2020-01-27
Results Overview
Observe the clinical pregnancy rate under different embryo transfer methods
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
335 participants
Primary outcome timeframe
4 weeks
Results posted on
2020-01-27
Participant Flow
Participant milestones
| Measure |
Self-spent Culture Medium
Changing embryo transfer solution with self-spent culture medium
Self-spent Culture Medium: Replace embryo transfer solution with Self-spent culture medium in IVF-ET.
|
New Culture Medium
embryo transfer with new culture medium in IVF-ET
|
|---|---|---|
|
Overall Study
STARTED
|
160
|
175
|
|
Overall Study
COMPLETED
|
150
|
168
|
|
Overall Study
NOT COMPLETED
|
10
|
7
|
Reasons for withdrawal
| Measure |
Self-spent Culture Medium
Changing embryo transfer solution with self-spent culture medium
Self-spent Culture Medium: Replace embryo transfer solution with Self-spent culture medium in IVF-ET.
|
New Culture Medium
embryo transfer with new culture medium in IVF-ET
|
|---|---|---|
|
Overall Study
Abnormal embryo transfer operation
|
10
|
7
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Self-spent Culture Medium
n=150 Participants
Changing embryo transfer solution with self-spent culture medium
Self-spent Culture Medium: Replace embryo transfer solution with Self-spent culture medium in IVF-ET.
|
New Culture Medium
n=168 Participants
embryo transfer with new culture medium in IVF-ET
|
Total
n=318 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
30.31 years
STANDARD_DEVIATION 4.08 • n=150 Participants
|
29.72 years
STANDARD_DEVIATION 4.77 • n=168 Participants
|
29.99 years
STANDARD_DEVIATION 4.11 • n=318 Participants
|
|
Sex: Female, Male
Female
|
150 Participants
n=150 Participants
|
168 Participants
n=168 Participants
|
318 Participants
n=318 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=150 Participants
|
0 Participants
n=168 Participants
|
0 Participants
n=318 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
China
|
150 Participants
n=150 Participants
|
168 Participants
n=168 Participants
|
318 Participants
n=318 Participants
|
|
duration of infertility
|
3.44 years
STANDARD_DEVIATION 2.24 • n=150 Participants
|
3.58 years
STANDARD_DEVIATION 3.39 • n=168 Participants
|
3.51 years
STANDARD_DEVIATION 2.97 • n=318 Participants
|
PRIMARY outcome
Timeframe: 4 weeksObserve the clinical pregnancy rate under different embryo transfer methods
Outcome measures
| Measure |
Self-spent Culture Medium
n=150 Participants
Changing embryo transfer solution with self-spent culture medium
Self-spent Culture Medium: Replace embryo transfer solution with Self-spent culture medium in IVF-ET.
|
New Culture Medium
n=168 Participants
embryo transfer with new culture medium in IVF-ET
|
|---|---|---|
|
Number of Participants Pregnant After 4 Weeks
|
85 Participants
|
82 Participants
|
PRIMARY outcome
Timeframe: 40 weeksObserve the live birth rate under different embryo transfer methods
Outcome measures
| Measure |
Self-spent Culture Medium
n=150 Participants
Changing embryo transfer solution with self-spent culture medium
Self-spent Culture Medium: Replace embryo transfer solution with Self-spent culture medium in IVF-ET.
|
New Culture Medium
n=168 Participants
embryo transfer with new culture medium in IVF-ET
|
|---|---|---|
|
Live Birth
|
78 Participants
|
74 Participants
|
Adverse Events
Self-spent Culture Medium
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
New Culture Medium
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. bin wu
Reproductive medcine of Jinan central hospatil
Phone: +86 053185695203
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place